Ethos Financial Group, LLC

SEC CIK: 0001954242
Latest filing: Aug 7, 2026

SEC filings (opens in a new tab)

CTMX holding history

CytomX Therapeutics, Inc. in every 13F filed by Ethos Financial Group, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CTMX overview All 13F holders of CTMX Full Q2 2026 holdings

Shares (Q2 2026): 0; Sold out in Q2 2026
Value: $0
% of portfolio: 0.0%
Quarters held: 3; Since Q3 2025

Holdings of CTMX by Ethos Financial Group, LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	0	$0	0.0%	−23,697−100.0%	Sold out	Holders
Q1 2026	23,697	$100.9K	<0.1%	00.0%	Unchanged	Holders
Q4 2025	23,697	$100.9K	<0.1%	00.0%	Unchanged	Holders
Q3 2025	23,697	$75.6K	<0.1%	+23,697	New	Holders